What Lanleys International Inc. does

Lanleys International Inc., per available firmographics, is a private specialty life-sciences supplier that focuses on mouse monoclonal antibodies and custom antibody production services for research applications. Its offerings sit within the contract-research / research-reagent segment of the biotech tools market, serving laboratories that require bespoke antibody reagents rather than off-the-shelf catalog products. The company's principal address is listed as Laval, Canada, although one third-party data source inferred a U.S. domicile based on the "Inc." corporate suffix; no incorporation jurisdiction was explicitly confirmed in the available material.

Operational, technical, and commercial evidence is extremely thin in the aggregated source set. The company's website (lanleys.com) returned a generic "Please wait while your request is being verified" loader page during data collection, exposing no product catalog, pricing, technology stack, certifications, patents, management bios, or customer disclosures. There are no documented funding rounds, headcount figures, partnerships, regulatory filings, or strategic transactions in the available record, and the firm's operating status could not be directly verified beyond a default "operating" classification. As a result, the company's actual revenue model, customer mix, technology architecture, and go-to-market motion cannot be characterized with confidence from the current inputs; the description above relies on the single short firmographic descriptor that was successfully aggregated.

Name

Lanleys International Inc.

Legal name

Lanleys International Inc.

Website

https://lanleys.com

Company type

Private

Operating status

Operating

Short description

Lanleys International Inc. is a private Laval, Canada-based supplier specializing in mouse monoclonal antibodies and custom antibody production services for research applications, serving laboratory and biotech research customers.

Ownership category

akta.pro rank

Product category

Antibody Production Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Monoclonal antibodies
• Custom antibody production
• Antibody services
• Research reagents
• Life sciences

Headquarters

HQ city

Laval

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D

Core offering

Lanleys International specializes in mouse monoclonal antibodies and provides custom antibody production services for research applications. The company supplies research-grade antibody reagents and offers tailored antibody development services to support life sciences and biomedical research needs.

Differentiator

Problem solved

Functional benefit

Products and services

• Mouse Monoclonal Antibodies
• Custom Antibody Production Services

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• GenScript: GenScript is a global biotech offering custom antibody production services, peptide synthesis, and gene synthesis. It directly competes with Lanleys in the custom monoclonal antibody services space.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology supplies antibodies for research applications across many target areas. It is a direct competitor in the research monoclonal and polyclonal antibody market.
• Rockland Immunochemicals: Rockland Immunochemicals manufactures antibodies and antibody-based reagents for research and diagnostic applications. It is a comparable niche supplier competing in custom and catalog antibody production.
• Cell Signaling Technology: Cell Signaling Technology produces and licenses high-quality antibodies for life science research. It competes directly in the research antibody reagent market with a strong catalog and customization offerings.
• ProSci Incorporated: ProSci is a custom antibody service provider specializing in polyclonal and monoclonal antibody production for research. It is a direct peer in custom antibody production services.

Broad incumbents

• Charles River Laboratories: Charles River provides research models and services including custom antibody production through its research models and services segments. It competes as a larger, diversified life science services company.
• Abcam: Abcam is a leading provider of research-grade antibodies with extensive catalog offerings. It serves the same research customer base and competes in antibody reagents, though at much greater scale.
• Thermo Fisher Scientific: Thermo Fisher offers a broad life sciences portfolio including research antibodies through its Invitrogen and other brands. It is a much larger incumbent in the antibody reagent market.
• Labcorp: Labcorp operates a large diagnostics and life sciences research business with antibody-related capabilities. It is a broad incumbent serving overlapping research and diagnostic end markets.
• Bio-Rad Laboratories: Bio-Rad supplies life science research products including antibodies, reagents, and instruments. It competes broadly with Lanleys in the research antibody and reagents space.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lanleys International Inc.